rs1008210645
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_001101426.4(CRPPA):c.636A>C(p.Glu212Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E212A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001101426.4 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CRPPA | NM_001101426.4 | c.636A>C | p.Glu212Asp | missense_variant | Exon 3 of 10 | ENST00000407010.7 | NP_001094896.1 | |
| CRPPA | NM_001368197.1 | c.636A>C | p.Glu212Asp | missense_variant | Exon 3 of 9 | NP_001355126.1 | ||
| CRPPA | NR_160656.1 | n.852A>C | non_coding_transcript_exon_variant | Exon 3 of 8 | ||||
| CRPPA | NM_001101417.4 | c.534+29921A>C | intron_variant | Intron 2 of 8 | NP_001094887.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152186Hom.:  0  Cov.: 32 show subpopulations 
GnomAD4 exome  AF:  6.85e-7  AC: 1AN: 1460134Hom.:  0  Cov.: 30 AF XY:  0.00000138  AC XY: 1AN XY: 726186 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152186Hom.:  0  Cov.: 32 AF XY:  0.0000134  AC XY: 1AN XY: 74350 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2U    Uncertain:1 
ACMG classification criteria: PM2 moderated -
not provided    Uncertain:1 
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U    Uncertain:1 
This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 212 of the ISPD protein (p.Glu212Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ISPD-related conditions. ClinVar contains an entry for this variant (Variation ID: 497567). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ISPD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at